Search Results - "Prue, R L"

Practical blood dendritic cell vaccination for immunotherapy of multiple myeloma by Vari, F., Munster, D. J., Hsu, J. L., Rossetti, T. R., Mahler, S. M., Gray, P. P., Turtle, C. J., Prue, R. L., Hart, D. N. J.

“…Summary Therapeutic vaccination combined with new drugs may cure multiple myeloma (MM). We have developed a bio‐process to purify CMRF‐56 monoclonal antibody…”
Get full text

Serum thrombopoietin levels in patients with aplastic anaemia by Marsh, J C, Gibson, F M, Prue, R L, Bowen, A, Dunn, V T, Hornkohl, A C, Nichol, J L, Gordon-Smith, E C

“…Endogenous serum thrombopoietin (TPO) levels were measured in 31 patients with aplastic anaemia (AA) using an enzyme immunoassay with a sensitivity of 20 pg/…”
Get more information

G‐CSF‐mobilized CD34+ peripheral blood stem cells are significantly less apoptotic than unstimulated peripheral blood CD34+ cells: role of G‐CSF as survival factor by Philpott, N. J., Prue, R. L., Marsh, J. C. W., Gordon‐Smith, E. C., Gibson, F. M.

“…The mechanism of release of CD34+ cells into the peripheral blood (PB) after mobilization treatment with chemotherapy and/or growth factors is not clearly…”
Get full text

Dendritic cell uptake of human apoptotic and necrotic neutrophils inhibits CD40, CD80, and CD86 expression and reduces allogeneic T cell responses: Relevance to systemic vasculitis by Clayton, Abigail R., Prue, Rebecca L., Harper, Lorraine, Drayson, Mark T., Savage, Caroline O. S.

“…Objective There is a breakdown of tolerance to neutrophil components during systemic vasculitis, which is marked by autoantibodies and T cells with specificity…”
Get full text